Technologies related to In vitro data available

Title
Engineering Neural Stem Cells Using Homologous Recombination
Ref: E-762-2013-0 | Updated: May 14, 2018
Role of Novel Hepatitis Delta Virus Variant in Sjogren’s Syndrome
Ref: E-736-2013-0 | Updated: Apr 14, 2014
Novel Small Molecule Antimalarials for Elimination of Malaria Transmission
Ref: E-751-2013-0 | Updated: Nov 18, 2015
Compositions and Methods for Improved Lyme Disease Diagnosis
Ref: E-204-2013-0 | Updated: Apr 3, 2014
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013-0 | Updated: May 14, 2018
Deconvolution Software for Modern Fluorescence Microscopy
Ref: E-038-2014-0 | Updated: Mar 18, 2014
Human Influenza Virus Real-time RT-PCR: Detection and Discrimination of Influenza A (H3N2) Variant from Seasonal Influenza A (H3N2) Viruses, Including H3v and Seasonal H3 Assays
Ref: E-562-2013-0 | Updated: Jul 25, 2018
Dengue Vaccines: Tools for Redirecting the Immune Response for Safe, Efficacious Dengue Vaccination
Ref: E-289-2013-0 | Updated: Mar 18, 2014
Rabies Vaccine for the Oral Immunization of Domesticated Animals, Wildlife and Feral Animals
Ref: E-470-2013-0 | Updated: May 24, 2016
Mining Safety: Personal Dust Monitor Filters for Accurate, Quantifiable Spectrometric Analysis and Assessment of Worker Exposure Levels
Ref: E-312-2013-0 | Updated: Mar 11, 2014
Computer Controlled Aerosol Generator with Multi-Walled Carbon Nanotube Inhalation Testing Capabilities
Ref: E-156-2013-0 | Updated: Mar 17, 2014
Multivalent, Multiple-Antigenic-Peptides for Serological Detection of HIV-1 Groups -M, -N, -O, and HIV-2
Ref: E-604-2013-0 | Updated: Feb 28, 2014
Methods for Amelioration and Treatment of Pathogen-associated Inflammatory Response
Ref: E-236-2013-0 | Updated: Feb 19, 2014
Recombinant Sulfated HIV Envelope Protein and Methods for Making Protein
Ref: E-067-2012-0 | Updated: Apr 15, 2014
Multiple Antigenic Peptide Assays for Detection of HIV and SIV Type Retroviruses
Ref: E-294-2013-0 | Updated: Feb 7, 2014
Peptide Sequences for Chlamydophila pneumoniae Vaccine and Serological Diagnosis
Ref: E-235-2013-0 | Updated: Feb 7, 2014
Novel In Vitro Granuloma Model for Studying Tuberculosis and Drug Efficacy
Ref: E-249-2013-0 | Updated: Feb 7, 2014
Diagnostic Antigens for the Identification of Latent Tuberculosis Infection
Ref: E-249-2013-1 | Updated: Feb 7, 2014
Methods for the Simultaneous Detection of Multiple Analytes
Ref: E-142-2013-0 | Updated: Feb 6, 2014
Automated Microscopic Image Acquisition, Compositing and Display Software Developed for Applied Microscopy/Cytology Training and Analysis
Ref: E-228-2013-0 | Updated: Feb 6, 2014
Methods of Retaining Methylation Pattern Information in Globally Amplified DNA
Ref: E-243-2013-0 | Updated: Feb 6, 2014
Enterovirus Molecular Diagnostic Test Kit
Ref: E-257-2013-0 | Updated: Feb 6, 2014
Recombinant Polypeptides for Clinical Detection of Taenia solium and Diagnosis of Cysticercosis
Ref: E-230-2013-0 | Updated: Feb 6, 2014
CD40 Ligand: Adjuvant for Enhanced Immune Response to Respiratory Syncytial Virus
Ref: E-233-2013-0 | Updated: Feb 6, 2014
Improved Botulism, Botulinum Neurotoxin Type-E Diagnostics
Ref: E-528-2013-0 | Updated: Jan 29, 2014
HIV-1 BED: A Simple Serological Assay for Detecting Recent Infection and Estimating Incidence of Multiple, Worldwide HIV-1 Subtypes
Ref: E-555-2013-0 | Updated: Jan 29, 2014
Vaccine Attenuation via Deoptimization of Synonymous Codons
Ref: E-328-2013-0 | Updated: Jan 28, 2014
Recombinant Nucleic-Acid Based Flavivirus Nucleic Acids for Development of Vaccines and/or Sero-diagnostics
Ref: E-341-2013-0 | Updated: Jan 28, 2014
Therapeutic, Bifunctional Janus Microparticles with Spatially Segregated Surface Proteins and Methods of Production
Ref: E-457-2013-1 | Updated: Jan 28, 2014
Stable, Early-stage Biomarker for Diagnosis of Bacillus anthracis Infection and Anthrax Vaccine Development
Ref: E-474-2013-0 | Updated: Mar 3, 2017
Simple, Rapid, and Sensitive Real-Time PCR Assays for Detecting Drug Resistance of HIV
Ref: E-198-2013-0 | Updated: Mar 12, 2018
Molecular Detection and Viral-Load Quantification for HIV-1 Groups M, N and O, and Simian Immunodeficiency Virus-cpz (SIVcpz)
Ref: E-271-2013-0 | Updated: Jan 28, 2014
Virus Replicon Particles as Rift Valley Fever Vaccines
Ref: E-272-2013-0 | Updated: Aug 8, 2016
Multi-Antigenic Peptide(s) Vaccine and Immunogen for Conferring Streptococcus pneumoniae Immunity
Ref: E-248-2013-1 | Updated: Jan 27, 2014
Select M. tuberculosis Peptides as Mucosal Vaccines Against Pulmonary Tuberculosis
Ref: E-192-2013-0 | Updated: Jan 27, 2014
Exposure and Activity Detection Assays for Anthrax Lethal Factor and Lethal Toxin
Ref: E-196-2013-0 | Updated: Mar 3, 2017
Real-time PCR Assays for Human Bocavirus Detection and Diagnosis
Ref: E-213-2013-0 | Updated: Jan 27, 2014
Detection of Retroviruses and HIV-1 Groups -M and -O Discrimination within Clinical Serum Samples
Ref: E-232-1993-0 | Updated: Jan 27, 2014
Device to Measure Muscle Contractile-Relaxant and Epithelial Bioelectric Responses of Perfused, Intact Tracheal Airways Tissue In Vitro
Ref: E-246-2013-0 | Updated: Jan 27, 2014
Virus Microneutralization Assay Data Analysis for Vaccine Development, Enhancement and Efficacy Improvement
Ref: E-262-2013-0 | Updated: Jan 27, 2014
Rapid Detection of Antiretroviral(s) Drug-Resistant HIV-1 within Clinical Samples
Ref: E-129-2013-0 | Updated: Jan 20, 2014
Immunogenic Hepatitis E Virus Polypeptides for Vaccine and Diagnostics Development
Ref: E-152-2013-0 | Updated: Jan 20, 2014
Antigen, Encoding Gene, Related Monoclonal Antibody and Hybridoma Clones for Streptococcus pneumoniae Serological Diagnostics
Ref: E-157-1991-0 | Updated: Jan 20, 2014
Use of Detector Response Curves to Optimize Settings for Mass Spectrometry
Ref: E-157-2013-0 | Updated: Jan 20, 2014
A Simple Colorimetric Assay for Anti-malarial Drugs Quality Assurance and Rapid, On-site Counterfeit Detection
Ref: E-161-2013-0 | Updated: Jan 20, 2014
Sensitive Method for Detection and Quantification of Anthrax, Bordetella pertussis, Clostridium difficile, Clostridium botulinum and Other Pathogen-Derived Toxins in Human and Animal Plasma
Ref: E-167-2013-0 | Updated: Mar 3, 2017
Multiplexed Immunoassay for Rapid Serological Diagnosis of a Specific Viral Infection in Clinical Samples
Ref: E-302-2013-0 | Updated: Jan 17, 2014
Methods of Treating or Preventing Pruritis (Itch)
Ref: E-485-2013-0 | Updated: Jun 7, 2018
Real-time RT-PCR Assay for the Detection of Rift Valley Fever Virus in Humans and Livestock
Ref: E-187-2013-0 | Updated: Jan 16, 2014
Controlled Expression and Assembly of Human Group-C Rotavirus-like Particles for Creation of Rotavirus Diagnostic Assays and Improved Vaccine Formulations
Ref: E-191-2013-2 | Updated: Dec 26, 2019
Respiratory Syncytial Virus Immunogens for Vaccine and Therapeutics Development
Ref: E-197-2013-0 | Updated: Jan 16, 2014
Universal Diagnostic Assay for Detection and Identification of Poxviruses in Clinical Samples
Ref: E-265-2013-0 | Updated: Jan 16, 2014
Real-time PCR and High Resolution Melt Analysis for Genotyping of Chlamydophila psittaci
Ref: E-266-2013-0 | Updated: Jan 23, 2014
Method for Finding Usable Portion of Sigmoid Curve (the Taylor Method), Improved Assay Readouts, and Enhanced Quality Control/Assurance
Ref: E-270-2013-0 | Updated: Jan 16, 2014
Novel Primate T-cell Lymphotropic Viruses (HTLV, STLV) for Development of Diagnostics, Therapeutics, Research Tools, and Vaccines
Ref: E-281-2013-0 | Updated: May 24, 2016
Diisocyanate Specific Monoclonal Antibodies for Occupational and Environmental Monitoring of Polyurethane Production Exposure-related Asthma and Allergy and Clinical Diagnosis
Ref: E-189-2013-0 | Updated: Jan 23, 2014
Detection and Differentiation of Pathogenic Fungi in Clinical Samples Using a Multi-Analyte Profiling System
Ref: E-293-2013-0 | Updated: Jan 23, 2014
Human Rotavirus Strains and Vaccines for Neonatal Childhood Protection
Ref: E-150-2013-0 | Updated: Dec 26, 2019
Novel Rift Valley Fever Virus Vaccines
Ref: E-254-2013-2 | Updated: Dec 23, 2013
Nucleic Acid-based Differentiation and Identification of Medically Important Fungi
Ref: E-332-2013-0 | Updated: Dec 23, 2013
Nucleic Acid-based Compositions and Methods for the Detection of Pathogenic Candida or Aspergillus Fungi Species
Ref: E-339-2013-0 | Updated: Dec 23, 2013
Nucleic Acid-based Compositions and Methods for the Species-Specific Detection of Pathogenic Candida Fungi
Ref: E-340-2013-0 | Updated: Dec 23, 2013
Improved Protein Quantification Process and Vaccine Quality Control Production
Ref: E-212-2013-0 | Updated: Dec 23, 2013
Species-specific Nucleic Acid Detection Assay for Fungi
Ref: E-232-2013-0 | Updated: Dec 23, 2013
Nucleic Acid Detection of the Fungal Pathogen Histoplasma capsulatum from Clinical and Environmental Samples
Ref: E-313-2013-0 | Updated: May 7, 2018
Nucleic Acid Assays for the Detection and Discrimination of Aspergillus Fungi Species within Biological Samples
Ref: E-335-2013-0 | Updated: May 7, 2018
Novel Epitopes of Bacillus anthracis Lethal Factor for Development of Diagnostics and Therapeutics
Ref: E-210-2013-0 | Updated: Mar 3, 2017
Use of Antisense Oligodeoxynucleotides for Inhibiting JC Virus
Ref: E-547-2013-0 | Updated: Feb 11, 2016
AAV-Aquaporin-1 Gene Therapy for Sjogren's Syndrome
Ref: E-139-2011-1 | Updated: May 1, 2019
Mouse Model for Methylmalonic Acidemia, an Inherited Metabolic Disorder
Ref: E-285-2011-1 | Updated: Dec 3, 2013
Intranasal Dry Powder Inhaler for Improved Delivery of Vaccines and Therapeutics
Ref: E-258-2013-0 | Updated: Dec 4, 2013
Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Ref: E-308-2013-0 | Updated: Jun 14, 2018
Diagnostics, Vaccines, and Delivery-Vehicles Related to Novel Phlebovirus
Ref: E-269-2013-0 | Updated: Dec 4, 2013
Human Influenza Virus Real-time RT-PCR Detection and Characterization Panel
Ref: E-331-2013-0 | Updated: Dec 4, 2013
Generation of Artificial Mutation Controls for Diagnostic Testing
Ref: E-255-2013-0 | Updated: May 24, 2016
Novel Vaccine for Prevention and Treatment of Chlamydia Infection
Ref: E-133-2012-0 | Updated: Aug 11, 2015
Derivatives of Docosahexaenoylethanolamide (DEA) for Neurogenesis
Ref: E-070-2012-0 | Updated: Nov 1, 2017
Glucocerebrosidase Non-inhibitory Chaperones for the Treatment of Gaucher Disease, Parkinson's Disease, and Other Proteinopathies
Ref: E-144-2012-0 | Updated: May 1, 2018
Capillary Viscometer for Measuring Viscosity of Macromolecular Solutions of Biological Relevance
Ref: E-231-2012-0 | Updated: Sep 6, 2016
Antagonists of Hyaluronan Signaling for Treatment of Airway Diseases
Ref: E-080-2012-0 | Updated: Sep 17, 2019
Human DNA Polymerase Gamma for Testing the Effect of Drugs on Mitochondrial Function
Ref: B-035-1998-0 | Updated: May 7, 2018
Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most HIV-1 Strains
Ref: E-253-2011-0 | Updated: Jun 18, 2014
Non-Contact Total Emission Detection Methods for Multiphoton Microscopy: Improved Image Fidelity and Biological Sample Analysis
Ref: E-236-2009-0 | Updated: Jul 8, 2014
Therapeutic Peptide Treatment for Dyslipidemic and Vascular Disorders
Ref: E-138-2008-0 | Updated: Aug 8, 2016
The Use of alpha-4 beta-7 integrin Inhibitors to Inhibit HIV Transmission and Infection
Ref: E-055-2007-0 | Updated: Feb 28, 2014
ApoA-1 Mimetic Peptides Promoting Lipid Efflux from Cells for Treatment of Vascular Disorders
Ref: E-114-2004-0 | Updated: Nov 29, 2016
Beta-Amyloid and Tau Fibril Positron Emissions Tomography (PET) Imaging Agents
Ref: E-156-2006-0 | Updated: Aug 17, 2016
Oral Treatment of Hemophilia
Ref: E-281-2001-0 | Updated: Dec 4, 2013

Pages

Subscribe to Technologies related to In vitro data available